KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 14 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,388,000 | +3.6% | 9,900,000 | 0.0% | 0.22% | +5.8% |
| Q4 2021 | $8,093,000 | +53.6% | 9,900,000 | +41.4% | 0.21% | +37.1% |
| Q3 2021 | $5,268,000 | -25.0% | 7,000,000 | 0.0% | 0.15% | -23.4% |
| Q2 2021 | $7,021,000 | +65.2% | 7,000,000 | +70.7% | 0.20% | +28.8% |
| Q1 2021 | $4,249,000 | -17.7% | 4,100,000 | 0.0% | 0.15% | -15.5% |
| Q4 2020 | $5,164,000 | +5.3% | 4,100,000 | 0.0% | 0.18% | +1.7% |
| Q3 2020 | $4,902,000 | -14.7% | 4,100,000 | 0.0% | 0.18% | -30.5% |
| Q2 2020 | $5,746,000 | -2.2% | 4,100,000 | 0.0% | 0.26% | +29.9% |
| Q1 2020 | $5,876,000 | -31.5% | 4,100,000 | -31.7% | 0.20% | +35.9% |
| Q4 2019 | $8,576,000 | – | 6,000,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 20,000,000 | $25,176,000 | 1.70% |
| DeepCurrents Investment Group LLC | 22,530,000 | $28,226,000 | 0.74% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $24,888,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 35,000,000 | $43,527,000 | 0.26% |
| AQR Arbitrage LLC | 4,100,000 | $5,164,000 | 0.18% |
| CSS LLC/IL | 3,000,000 | $3,781,000 | 0.14% |
| Verition Fund Management LLC | 6,579,000 | $8,286,000 | 0.07% |
| LAZARD ASSET MANAGEMENT LLC | 16,500,000 | $20,780,000 | 0.03% |
| Citadel Advisors | 43,300,000 | $54,252,000 | 0.01% |
| CREDIT SUISSE AG/ | 5,017,000 | $6,243,000 | 0.00% |